Pipeline

Orphan diseases

Disease
Project
Stage
MPS II, Hunter syndrome
Pre-clinical
Phase 1
Phase 2-3
Registration
Immune thrombocytopenic purpura
GNR-069
Pre-clinical
Phase 1
Phase 2-3
Registration

Autoimmune diseases

Plaque psoriasis
GNR-068 (interleukin inhibitor)
Pre-clinical
Phase 1
Phase 2-3
Registration

Vaccines

COVID-19
GNR-099 (nasal vaccine)
Pre-clinical
Phase 1
Phase 2-3
Registration

Oncology

Acute lymphoblastic leukemia
GNR-084 (bispecific antibody, T-cells engager)
Pre-clinical
Phase 1
Phase 2-3
Registration
Solid tumors
GNR-051 (PD-1 inhibitor)
Pre-clinical
Phase 1
Phase 2-3
Registration

Cardiovascular disorders

Myocardial Infarction
Pre-clinical
Phase 1
Phase 2-3
Registration

Ophtalmology

Macular degeneration
GNR-067 (ranibizumab)
Pre-clinical
Phase 1
Phase 2-3
Registration

ATMP

Autologus ATMP
GNR-089 (Cartilage implant)
Pre-clinical
Phase 1
Phase 2-3
Registration
Allogenic ATMP
GNR-080 (Regeneration stimulator)
Pre-clinical
Phase 1
Phase 2-3
Registration